Inventor
Paul William Glue
Inventor
Flemington, NJ, US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes69%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
PatentTitleYear
11,045,424Extended release pharmaceutical formulation202110,869,838Extended release pharmaceutical formulation202010,744,094Extended release pharmaceutical formulation202010,441,544Extended release pharmaceutical formulation20197,776,851'Use of neurokinin antagonists in the treatment of urinary incontinence'20106,849,254'HCV combination therapy'20056,824,768'Ribavirin-pegylated interferon alfa induction HCV combination therapy'20046,524,570'Polyethylene glycol modified interferon therapy'20036,262,049'Method of reducing nicotine and tobacco craving in mammals'20016,177,074'Polyethylene glycol modified interferon therapy'20015,908,621'Polyethylene glycol modified interferon therapy'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2005Patents assigned to SCHERING CORP (6)· patent assignee history
1999–2010Based in Flemington, NJ, US· patent location history
2010Patents assigned to NOVARTIS AG (1)· patent assignee history
2019–2021Patents assigned to DOUGLAS PHARMACEUTICALS LTD (4)· patent assignee history
2019–2021Based in Dunedin, NZ· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHERING CORP | 6 | 1999–2005 |
| DOUGLAS PHARMACEUTICALS LTD | 4 | 2019–2021 |
| NOVARTIS AG | 1 | 2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| Flemington, New Jersey, US | 7 | 1999–2010 |
| Dunedin, NZ | 4 | 2019–2021 |